N.O.R.T.H.

North Therapeutics is an Australian biotechnology company focused on developing next-generation RNA-based therapeutics. Spun out of the University of Queensland and closely integrated with the ARC Research Hub for Novel Oligonucleotide Research and Therapeutics (NORTH), the company leverages a proprietary platform to design and optimize antisense oligonucleotides (ASOs) and other nucleic acid modalities. Their research aims to overcome traditional delivery and stability challenges associated with RNA medicines to treat high-unmet-need areas such as rare genetic disorders, oncology, and neurological conditions. By utilizing advanced bioinformatics and molecular biology, North Therapeutics is positioning itself as a leader in the rapidly evolving field of precision RNA medicine.